Summary
Hims & Hers, a virtual healthcare platform, is partnering with Quest Diagnostics to offer direct-to-consumer lab tests. Patients can choose from various health tests and receive results directly, aiming to simplify the process of accessing personal health information.
Key Facts
- Hims & Hers has about 2.5 million subscribers and is adding lab testing services.
- The partnership with Quest Diagnostics will offer over 120 different biomarker tests.
- Tests cover health areas like heart, liver, and metabolic health.
- Patients can choose from two blood testing plans, costing $199 or $499 annually.
- Results will be provided through the Hims & Hers app, with guidance from over 2,000 medical providers.
- Quest Diagnostics has more than 6,000 locations across the U.S. to conduct these tests.
- Direct-to-consumer lab testing is a growing market, expected to reach nearly $6 billion in value by 2025.
- A survey found that 96% of patients want faster access to their lab results.
